The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Agreement

9 Oct 2012 08:02

RNS Number : 2410O
AorTech International PLC
09 October 2012
 



AorTech International plc

 

AorTech lnternational plc alleges material breach of contract by division of St Jude Medical

 

 

Shareholders are aware that a principal commercial contract of AorTech International pic ("AorTech" or the "Company") and its subsidiaries (''the AorTech Group") is an agreement (the "Agreement") for the license and supply of AorTech's proprietary materials to Pacesetter Inc. dba St. Jude Medical Cardiac Rhythm Management Division ("St. Jude").

AorTech and its subsidiaries have served on St Jude a Rectification Notice which asserts material breaches by St. Jude under the Agreement and related agreements. To the extent the asserted breaches are capable of cure, the Rectification Notice provides for a 30 day Rectification Period for St. Jude to cure. The Board is informed and believes that the material breaches are likely not capable of cure.

During the Rectification Period, the AorTech Group will continue to meet its obligations to St Jude under the Agreement. If St. Jude's breaches have not been cured within the Rectification Period, the AorTech Group is entitled under the Agreement at its absolute discretion to terminate the Agreement, including all licenses and other rights for St. Jude to use AorTech's materials or intellectual property, other than use of materials already held by St. Jude. The Board has voted to terminate the Agreement if the material breaches are not cured. If termination occurs St Jude will continue to own the necessary assets to manufacture polymers but will no longer have the rights in the Company's intellectual property and know how to manufacture the proprietary AorTech materials.

The material breaches of the AorTech Group's largest contract, the serving of the Rectification Notice, the Board's informed belief that the material breaches are likely not capable of cure and AorTech's decision to terminate the contract if the material breaches are not cured together constitute a significant development and as required by the AIM Rules, AorTech is making this notification without delay.

 

 

AorTech International plc

Bill Brown, Chairman

Tel: +44 (0) 7730 718296

 

finnCap

Stuart Andrews/Rose HerbertfinnCap as Nominated AdviserTel: 020 7220 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREAXENEEEAFEF
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.